摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2-(2-Formamido-4-thiazolyl)-2-(1-tert-butoxycarbonyl-1-methyl)ethoxyiminoacetic acid | 90467-56-4

中文名称
——
中文别名
——
英文名称
(Z)-2-(2-Formamido-4-thiazolyl)-2-(1-tert-butoxycarbonyl-1-methyl)ethoxyiminoacetic acid
英文别名
2-(2-formamidothiazol-4-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetic acid;(2Z)-2-(2-formamido-1,3-thiazol-4-yl)-2-[2-methyl-1-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]oxyiminoacetic acid
(Z)-2-(2-Formamido-4-thiazolyl)-2-(1-tert-butoxycarbonyl-1-methyl)ethoxyiminoacetic acid化学式
CAS
90467-56-4
化学式
C14H19N3O6S
mdl
——
分子量
357.387
InChiKey
KLRKYWXDKHOMMY-MFOYZWKCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    24
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    155
  • 氢给体数:
    2
  • 氢受体数:
    9

反应信息

点击查看最新优质反应信息

文献信息

  • 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for
    申请人:Fujisawa Pharmaceutical, Co., Ltd.
    公开号:US04409214A1
    公开(公告)日:1983-10-11
    This invention relates to novel 7-acylamino-3-vinyl-cephalosporanic acid derivatives and pharmaceutically acceptable salts thereof, of high antimicrobial activity.
    这项发明涉及具有高抗微生物活性的新型7-酰氨基-3-乙烯-头孢菌素酸衍生物及其药用盐。
  • 3-Phosphonium and 3-phosphoranylidenecephems
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04487927A1
    公开(公告)日:1984-12-11
    This invention relates to novel 7-acylamino-3-vinylcephalosporanic acid derivatives of high antimicrobial activity, to processes for preparation thereof from novel intermediates, and to said intermediates of the formula: ##STR1## in which R.sub.A is a group of the formula: ##STR2## wherein R.sup.1 is amino-substituted-heterocyclic group which may have halogen, protected amino-substituted-heterocyclic group which may have halogen, or a group of the formula: ##STR3## wherein R.sup.3 is lower alkyl, R.sup.8 is aryl, A is lower alkylene which may have a substituent selected from the group consisting of amino, a protected amino group, hydroxy, oxo and a group of the formula: .dbd.N.about.OR.sup.4, wherein R.sup.4 is hydrogen, cyclo(lower)alkenyl, lower alkynyl, lower alkenyl, lower alkenyl substituted by carboxy or a protected carboxy group, lower alkyl, or lower alkyl substituted by one or more substituent(s) selected from carboxy, a protected carboxy group, amino, a protected amino group, cyano, phosphono, a protected phosphono group and a heterocyclic group which may have suitable substituent(s), R.sup.a is a protected amino group, R.sup.b is a protected carboxy group, R.sub.B is a group of the formula: --CH.sub.2 --X.sup.2, --CH.sub.2 P.sup..sym. (R.sup.7).sub.3 .multidot.X.sup.3.crclbar. or --CH.dbd.P(R.sup.7).sub.3 wherein R.sup.7 is aryl, and X.sup.2 and X.sup.3 are each halogen, and R.sup.2 is carboxy or a protected carboxy group, provided that, when R.sub.A is a group of the formula: R.sup.8 --CH.dbd.N--, wherein R.sup.8 is as defined above, then R.sub.B is a group of the formula: --CH.sub.2 P.sup..sym. (R.sup.7).sub.3 .multidot.X.sup.3.crclbar. or --CH.dbd.P(R.sup.7).sub.3, wherein R.sup.7 and X.sup.3 are each as defined above, or a salt thereof.
    这项发明涉及具有高抗菌活性的新型7-酰氨基-3-乙烯头霉素酸衍生物,以及从新型中间体制备它们的方法,以及所述的具有以下结构的中间体:##STR1## 其中R.sub.A是以下结构的基团:##STR2## 其中R.sup.1是氨基取代的杂环基团,可能具有卤素,受保护的氨基取代的杂环基团,可能具有卤素,或者以下结构的基团:##STR3## 其中R.sup.3是较低的烷基,R.sup.8是芳基,A是可能具有来自氨基、受保护的氨基基团、羟基、氧代或以下结构的取代基团的取代基团的较低烷基,其中R.sup.4是氢、环(较低)烯基、较低炔基、较低烯基、较低烯基取代的羧基或受保护的羧基、较低烷基,或者较低烷基取代的一个或多个取代基团,所述取代基团选自羧基、受保护的羧基、氨基、受保护的氨基基团、氰基、磷酸基、受保护的磷酸基团和可能具有适当取代基团的杂环基团,R.sup.a是受保护的氨基基团,R.sup.b是受保护的羧基团,R.sub.B是以下结构的基团:--CH.sub.2 --X.sup.2、--CH.sub.2 P.sup..sym. (R.sup.7).sub.3 .multidot.X.sup.3.crclbar.或--CH.dbd.P(R.sup.7).sub.3,其中R.sup.7是芳基,X.sup.2和X.sup.3分别是卤素,R.sup.2是羧基或受保护的羧基团,但是当R.sub.A是以下结构的基团时:R.sup.8 --CH.dbd.N--,其中R.sup.8如上定义,那么R.sub.B是以下结构的基团:--CH.sub.2 P.sup..sym. (R.sup.7).sub.3 .multidot.X.sup.3.crclbar.或--CH.dbd.P(R.sup.7).sub.3,其中R.sup.7和X.sup.3如上定义,或其盐。
  • Prodrugs activated by targeted catalytic proteins
    申请人:Kenten Henry John
    公开号:US20050123533A1
    公开(公告)日:2005-06-09
    Disclosed and claimed are prodrugs activated by catalytic proteins, such as enzymes and catalytic antibodies. The invention comprehends such prodrugs, as well as haptens, to elicit catalytic antibodies to activate the prodrugs. The prodrugs are useful as cytotoxic chemotherapeutic agents; e.g., as antitumor agents.
    本发明揭示和声明了通过催化蛋白质(如酶和催化抗体)激活的前药。该发明涵盖了这样的前药,以及半抗原,以引发催化抗体以激活前药。这些前药可用作细胞毒性化疗剂,例如,作为抗肿瘤剂。
  • Orally Active Cephalosporins. Part 4: Synthesis, Structure–Activity Relationships and Oral Absorption of Novel 3-(4-Pyrazolylmethylthio)cephalosporins with Various C-7 Side Chains
    作者:Hirofumi Yamamoto、Yoshiteru Eikyu、Shinya Okuda、Kohji Kawabata、Hisashi Takasugi、Hirokazu Tanaka、Satoru Matsumoto、Yoshimi Matsumoto、Shuichi Tawara
    DOI:10.1016/s0968-0896(01)00416-3
    日期:2002.5
    A series of 3-(4-pyrazolylmethylthio)cephalosporins with various C-7 side chains was designed, synthesized and evaluated for antibacterial activity and oral absorption in rats. Antibacterial activity against Haemophilus influenzae was markedly increased by the C-7 oxime moiety. Deamination at the 2 position of, or introduction of a substituent such as halogen or methyl to, the 5 position of the (Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino) moiety improved oral absorption. Among these compounds, FR192752 (40a) having a (Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-hydroxyiminoacetam do moiety, showed potent antibacterial activity against both Gram-positive and Gram-negative bacteria including H. influenzae and penicillin G-resistant Streptococcus pneumoniae (PRSP). Further, it showed higher oral absorption than CFDN and FK041. (C) 2002 Elsevier Science Ltd, All rights reserved.
  • INAMOTO, YOSHIKO;CHIBA, TOSHIYUKI;SAKANE, KAZUO;KAMIMURA, TOSHIAKI;TAKAYA+, YAKUGAKU DZASSI, 110,(1990) N, S. 246-257
    作者:INAMOTO, YOSHIKO、CHIBA, TOSHIYUKI、SAKANE, KAZUO、KAMIMURA, TOSHIAKI、TAKAYA+
    DOI:——
    日期:——
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰